CannaZen
CannaZen operates a German medical cannabis telemedicine platform connecting patients with licensed physicians for online prescriptions, fulfilled through a partner pharmacy network and delivered nationwide within 48 hours. It serves chronic-condition patients with flowers, extracts, and edibles.
- Company typePrivate
- Founded2024
- HeadquartersCologne, Germany
- Headcount1–10
- GTM typeB2C
- OfferingServices
What CannaZen does
CannaZen (legally Avimed Ltd, registered in Nicosia, Cyprus) operates a German-facing digital telemedicine platform for medical cannabis prescriptions, headquartered commercially in Cologne. Patients complete an online questionnaire, are reviewed by cooperating licensed physicians (with typical response times of 5-90 minutes on weekdays), and receive prescriptions that are routed to a network of three partner pharmacies (Königs Apotheke Nürnberg, Vitahris Apotheke Bad Neuenahr-Ahrweiler, Canndirekt Euskirchen) for fulfillment and discrete DHL delivery within 48 hours across Germany. The platform offers more than 85 cannabis flower strains and extracts, sourced from licensed German manufacturers including Cannamedical, Demecan, Remexian Pharma, and LUANA, with prices starting at €3.99 per gram and a one-time prescription consultation fee of €9.99.
The technology stack is an integration/interoperability layer rather than a proprietary clinical system: a web storefront and native iOS/Android applications that connect patient intake, physician review, prescription transmission, and pharmacy fulfillment. Marketing relies on an extensive educational content library (cannabis wiki, condition guides, cannabinoid and terpene explainers), SEO, organic social across YouTube, Instagram, TikTok, Facebook, LinkedIn, Pinterest, Telegram, and WhatsApp, plus earned media coverage in BILD Zeitung, RTL Plus, and Deutsche Startups. A DHV (Deutscher Hanfverband) membership anchors regulatory and community positioning.
CannaZen monetizes through a €9.99 one-time consultation fee and a margin on product sales routed through partner pharmacies, with free shipping above €100 and Trusted Shops buyer protection. The company serves German patients with chronic pain, sleep disorders, stress and anxiety, ADHD, depression, migraines, and appetite loss. It claims 57,000-76,000+ patients served and a 4.7/5.0 rating across more than 2,000 reviews, while operating with a 1-10 person team. A December 2024 funding round of approximately $527,200 was the disclosed capital event.
CannaZen firmographics
Firmographics- Name
- CannaZen
- Legal name
- Avimed Ltd
- Website
- https://cannazen.de
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CannaZen operates a German medical cannabis telemedicine platform connecting patients with licensed physicians for online prescriptions, fulfilled through a partner pharmacy network and delivered nationwide within 48 hours. It serves chronic-condition patients with flowers, extracts, and edibles.
- Ownership category
- akta.pro rank
CannaZen industry classification
Industry- Product category
- Medical Cannabis Telemedicine
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (62142)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)
- akta.pro secondary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
Keywords
Where CannaZen is headquartered
LocationHeadquarters
- HQ city
- Cologne
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
CannaZen business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Infrastructure
Revenue model
- Prescription Consultation Fee: One-time fee of 9.99€ for treatment request/consultation, including initial or follow-up prescription issuance by cooperating physicians.
- Cannabis Product Sales: Revenue from sale of medical cannabis flowers and extracts through the platform. Products range from 3.99€ per gram for flowers up to 99.99€ for extracts. Free shipping on orders over 100€.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Prescription consultation fee for medical cannabis treatment |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels9 records
CannaZen product offering
Product offeringCore offering
CannaZen operates a fully digital telemedicine platform that connects German patients with licensed cooperating physicians for medical cannabis consultations and prescriptions, with fulfillment through a network of partner pharmacies and discreet 48-hour DHL delivery across Germany. The platform offers over 85 cannabis strains and extracts, with a one-time 9.99€ consultation fee plus product purchases starting at 3.99€ per gram.
Product overview
CannaZen is an online medical cannabis telemedicine platform that connects patients with licensed physicians for online consultations and prescriptions. The product portfolio includes cannabis Flowers available in multiple strains, Extracts such as Live Rosin solventless products, and Edibles including gummies. Products are delivered discreetly via partner pharmacies within 48 hours through DHL. The offering is complemented by an iPhone mobile application for digital prescription delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Online Medical Cannabis Consultation & Prescription Service
- Cannabis Flowers (Blüten)
- Cannabis Extracts
- Cannabis Edibles (THC Gummies)
- CannaZen Mobile App
Quantifiable outcome
- 57,000+ customers and 76,000+ patients served
- +3 more outcomes
Companies that use CannaZen
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles1 record
CannaZen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature3 records
CannaZen partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Deutscher Hanfverband (DHV)coreCannaZen is a member and sponsor of DHV (German Hemp Association), Germany's largest cannabis advocacy organization. This partnership provides credibility within the cannabis community and supports legalization efforts while enhancing brand reputation.
- Königs Apotheke NürnbergcorePartner pharmacy located at Königs Apotheke, Löwenberger Str. 16, 90475 Nürnberg. One of three partner pharmacies fulfilling medical cannabis prescriptions for CannaZen patients.
- Vitahris Apotheke Bad Neuenahr-AhrweilercorePartner pharmacy at Bergstr. 2, 53474 Bad Neuenahr-Ahrweiler. One of three partner pharmacies fulfilling medical cannabis prescriptions for CannaZen patients.
- Canndirekt EuskirchencorePartner pharmacy at Kuchenheimer Straße 117, 53881 Euskirchen. One of three partner pharmacies fulfilling medical cannabis prescriptions for CannaZen patients.
- Cooperative Physicians NetworkcoreNetwork of independent physicians who review patient treatment requests through CannaZen's platform. They typically process requests within 5-90 minutes on weekdays. The platform indicates when 4 physicians are online for consultations.
- Trusted ShopsminorTrusted Shops buyer protection certification providing 100% purchase protection for customers. CannaZen displays Trusted Shops certification badge and logo.
- DHLcoreShipping partner for discrete delivery of medical cannabis products. Provides 48-hour delivery service to patients across Germany.
- CannamedicalminorMajor German medical cannabis manufacturer/supplier whose products are sold through CannaZen's platform. Products include Papaya Boom, Gorilla Zkittlez, Wedding Tree, El Jefe, and various extracts.
- DemecanminorGerman medical cannabis manufacturer whose FE 800 No. 1 Live Rosin extract and other strains (Critical 47, Fruit Punch, Core Saxonia) are available through CannaZen.
- Remexian PharmaminorMedical cannabis manufacturer whose products (Oreoz, GWagon, Glitter Bomb, LA Baker, Sugar Dreams) are sold through CannaZen's platform.
- LUANAminorGerman medical cannabis brand whose products (Durban Poison, Solpina Magic) are sold through CannaZen's platform.
Scale indicators6 records
Recent moves6 records
Expansion highlights4 records
CannaZen competitors and assessment
Company assessmentOthers
- Cannamedical: Cannamedical is a leading German medical cannabis distributor supplying products (Creamy Kee's, Gummies, Papaya Boom, Gorilla Zkittlez) via CannaZen's platform. Adjacent ecosystem player in German medical cannabis distribution.
- DEMECAN: DEMECAN is a German medical cannabis producer (one of only a few licensed German cultivators) and supplier of products sold on CannaZen's platform (Critical 47, Fruit Punch, Core Saxonia). Comparable as a German medical cannabis ecosystem player, but upstream supplier rather than retailer.
- Four20 Pharma: Four20 Pharma is a German medical cannabis producer and distributor supplying pharmacies across Germany. Comparable as a German medical cannabis ecosystem participant, though operating upstream in cultivation/distribution rather than telemedicine.
Direct peers
- Bloomwell Group: Bloomwell is a Frankfurt-based German medical cannabis e-commerce and telemedicine platform connecting patients with physicians for cannabis prescriptions. Competes directly with CannaZen in the digital-first medical cannabis prescribing space.
- Grünhorn (Sanity Group): Grünhorn is a German medical cannabis telemedicine and pharmacy platform operated by Sanity Group. It is the closest direct competitor to CannaZen, offering online doctor consultations, prescriptions, and nationwide cannabis delivery with a similar omnichannel model.
- Cansativa: Cansativa is a German cannabis wholesale and e-commerce platform distributing medical cannabis to pharmacies and patients nationwide. Direct competitor in the German medical cannabis distribution and digital ordering layer.
Regional players
- Bedrocan: Bedrocan is the Dutch government-licensed medical cannabis producer supplying pharmacy-grade cannabis across Europe. Comparable as a medical cannabis supplier/distributor ecosystem participant serving the German market, though based in the Netherlands.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CannaZen social profiles
Digital presenceCannaZen financial estimates
Financial estimateRevenue estimate
Valuation estimate
CannaZen leadership team
Management profileNumber of profiles
CannaZen funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CannaZen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CannaZen
What does CannaZen do?
CannaZen operates a fully digital telemedicine platform that connects German patients with licensed cooperating physicians for medical cannabis consultations and prescriptions, with fulfillment through a network of partner pharmacies and discreet 48-hour DHL delivery across Germany. The platform offers over 85 cannabis strains and extracts, with a one-time 9.99€ consultation fee plus product purchases starting at 3.99€ per gram.
Is CannaZen a public or private company?
CannaZen is a private company. It is classified as unknown and is currently operating.
When was CannaZen founded?
CannaZen was founded in 2024. It employs 1 to 10 people.
Where is CannaZen based?
CannaZen is headquartered in Cologne, Germany, in the Europe region.
How does CannaZen make money?
Two revenue lines are on record. Prescription Consultation Fee is the primary driver. The others are cannabis Product Sales.
Who are CannaZen's main competitors?
Others on record are Cannamedical, DEMECAN and Four20 Pharma. Direct peers are Bloomwell Group, Grünhorn (Sanity Group) and Cansativa. Bedrocan is listed as a regional player.
Does CannaZen have an API?
No public API is recorded for CannaZen.
What industry is CannaZen in?
CannaZen's product category is Medical Cannabis Telemedicine. Its primary akta.pro industry code is CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail), with a secondary code of CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 62142 and its SIC code is 5912.